Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Hepatology., Sep;36(3):729-36 (2002)
Risks of a range of alcohol intake on hepatitis C-related fibrosis.
Hepatology., Mar;39(3):826-34 (2004)
Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
Hepatology., Aug;42(2):310-6 (2005)
Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients.
Am. J. Gastroenterol., Jul;101(7):1509-15 (2006)
Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.
Eur J Gastroenterol Hepatol., Feb;21(2):225-9 (2009)
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.
Am. J. Gastroenterol., May;105(5):989-1004; quiz 988, 1005 (2010)
Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.
Dig. Dis. Sci., Aug;56(8):2439-48 (2011)
Liver disease in injection drug users with hepatitis C, with and without HIV coinfection.
J Addict Dis., 27(2):49-59 (2008)
Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.
Int J Biostat., 6(1):Article 7 (2010)
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop
American Journal of Gastroenterology
Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study
Journal of Cardiac Failure